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Rho proteins, members of the Ras superfamily of GTPases, are critical elements in signal trans-
duction pathways governing cell proliferation and cell death. Different members of the family of
human Rho GTPases, including RhoA, RhoC, and Rac1, participate in the regulation of apoptosis
in response to cytokines and serum deprivation in different cell systems. Here, we have charac-
terized the mechanism of apoptosis induced by Rac1 in NIH 3T3 cells. It requires protein synthesis
and caspase-3 activity, but it is independent of the release of cytochrome c from mitochondria.
Moreover, an increase in mitochondria membrane potential and the production of reactive oxygen
species was observed. Rac1-induced apoptosis was related to the simultaneous increase in
ceramide production and synthesis of FasL. Generation of FasL may be mediated by transcrip-
tional regulation involving both c-Jun amino terminal kinase as well as nuclear factor-kB-
dependent signals. None of these signals, ceramides or FasL, was sufficient to induce apoptosis in
the parental cell line, NIH 3T3 cells. However, any of them was sufficient to induce apoptosis in
the Rac1-expressing cells. Finally, inhibition of FasL signaling drastically reduced apoptosis by
Rac1. Thus, Rac1 seems to induce apoptosis by a complex mechanism involving the generation of
ceramides and the de novo synthesis of FasL. These results suggest that apoptosis mediated by
Rac1 results from a signaling mechanism that involves biochemical and transcriptional events
under control of Rac1.
INTRODUCTION
Apoptosis, or programmed cell death, is a genetically con-
trolled, tightly regulated process in development and mor-
phogenesis. Unregulated excessive apoptosis may be the
cause of various degenerative diseases such as Alzheimer or
Parkinson (Cotman and Anderson, 1995), whereas an inap-
propriately low rate of apoptosis may promote survival and
accumulation of abnormal cells that can give rise to autoim-
mune diseases and cancer (Thompson et al., 1995). During
apoptosis, a cell activates an intrinsic suicide mechanism
with characteristic alterations that include chromatin con-
densation, cytoplasmic vacuolization, plasma membrane
blebbing, and DNA fragmentation (reviewed in Martin et al.,
1994; White, 1996). The process of apoptosis is controlled
through the expression of a number of genes conserved from
nematodes through vertebrates. Some gene products are
activators of apoptosis, whereas others are inhibitors (re-
viewed in Green, 1998).
It has long been accepted that some oncogenes and onco-
suppressor genes are involved in cell death as well as in
proliferation. The Rho GTPases form a subgroup of the Ras
superfamily of GTP binding proteins that regulate a wide
spectrum of cellular functions. The Rho GTPases function
cycling between an active GTP-bound state and an inactive
GDP-bound state. After the original cloning of rho gene in
Aplysia californica (Madaule and Axel, 1985), several mam-
malian genes have been identified and divided into various
subclasses: Rho (A, B, and C isoforms), Rac (1, 2, and 3
isoforms), Cdc42 (HsCdc42 and G25K isoforms), Rho D, Rho
G, Rho E, and TC10 (Chardin et al., 1988; Didsbury et al.,
1989; Shinjo et al., 1990; Vincent et al., 1992; Haataja et al.,
1997).
Activated Rho GTPases interact with intracellular target
proteins or effectors to trigger a wide variety of cellular
responses, including the reorganization of the actin cytoskel-
eton, cell cycle progression, adhesion, metastasis, and gene
transcription (reviewed in Van Aelst and D’Souza-Schorey,
1997). Some members of the Rho GTPase family also play a
role in apoptosis. On such behalf we have previously re-
ported that A. californica rho gene and the human genes rho
A, rho C, and rac 1 are capable of inducing apoptosis in
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different cell systems such as NIH 3T3 fibroblasts and the
human erythroleukemia K562 cell line after serum depriva-
tion (Esteve et al., 1995, 1998; Jime´nez et al., 1995). We have
investigated the mechanism involved in this process and
have demonstrated that apoptosis induced by Rho proteins
is independent of p53 and is sensitive to expression of Bcl 2
protein in vivo and in vitro (Esteve et al., 1998). Furthermore,
overexpression of rho, correlated with an increase in cer-
amide levels (Esteve et al. 1995, 1998), a putative second
messenger for apoptosis (Obeid et al., 1993; Hannun, 1994;
Jarvis et al., 1994; Testi, 1996). Furthermore, it was then
verified that Rho-induced apoptosis is indeed mediated by
generation of ceramides. Moreover, vav and ost (Horii et al.,
1994; Crespo et al., 1996) two guanine exchange factors for
Rho proteins with oncogenic properties, were also able to
induce apoptosis under similar conditions. We have seen
also that Rho proteins play an important role in the physi-
ological regulation of the apoptotic response to stress-induc-
ing agents because a dominant-negative mutant of Rac 1
interferes with the induction of apoptosis by tumor necrosis
factor-a (Esteve et al., 1998).
Numerous groups have reported that both the c-Jun
amino terminal kinase (JNK) and p38 pathways can be ac-
tivated by Rac and Cdc42. Moreover, we have recently dem-
onstrated that the human Rho A, Rac-1, and Cdc42 proteins
efficiently induce the transcriptional activity of nuclear fac-
tor-kB (NF-kB), and that activation of serum response factor
by Rho A is mediated by NF-kB and CAAT enhancer bind-
ing protein b (c/EBPb) transcription factors (Perona et al.,
1997; Montaner et al., 1998, 1999). These results strongly
implicate Rho proteins in the regulation of signaling path-
ways leading to the nucleus. Both JNK and NF-kB have been
proposed as dual signaling pathways that can be involved in
either survival/transforming or apoptotic events. Therefore,
both pathways could be involved in the apoptotic responses
mediated by Rho proteins. In keeping with this, recent stud-
ies indicate that overexpression of Cdc42 induces apoptosis
in Jurkat cells (Chuang et al., 1997), and that this response is
mediated by activation of a protein kinase cascade leading to
stimulation of JNK. On the other hand, Fas-induced apopto-
sis is mediated by activation of Ras and Rac signaling path-
way (Gulbins et al., 1996) and a new target for Rac called
POSH (plenty of SH2) induces apoptosis in NIH 3T3 cells
(Tapon et al., 1998). Further observations suggested that
caspase-3 is responsible for the degradation of p21, activated
kinase 2 (PAK-2), a direct effector for Rac and Cdc42 pro-
teins, and that activation of PAK-2 induces some of the
morphological changes of apoptosis. Finally, it has been
reported that transgenic mice carrying an activated version
of the Rac2 gene, under the control of the thymus-specific lck
proximal promoter, showed an increased apoptosis in the
thymus, the first in vivo demonstration of a role of Rho
proteins in apoptosis (Lores et al., 1997).
In an effort to elucidate the intracellular mechanism un-
derlying the induction of apoptosis by Rho GTPases, we
have investigated further the apoptotic process induced by
serum deprivation in NIH 3T3 cells stably overexpressing an
activated version of the Rac1 protein. A mechanism that
involves ceramides production, protein synthesis, as well as
caspase-3 activation, and independent of cytochrome c re-
lease has been found. Moreover, Rac-1 up-regulated the
transcriptional activity of the Fas ligand promoter, thereby
increasing its protein levels, by a mechanism that may in-
volve both JNK- and NF-kB-dependent signals.
MATERIALS AND METHODS
Reagents and Expression Plasmids
Tetrapeptide inhibitors for caspase-1, acetyl-YVAD aldehyde
(YVAD-CHO), caspase-3, N-acetyl DEVD-aldehyde (DEVD-CHO),
and tetrapeptide substrates for caspase-3 (Ac-DEVD-AMC) and
caspase-1 (Ac-YVAD-AMC) were from Research Biochemicals In-
ternational (Natick, MA). Purified anti-cytochrome c antibody was
purchased from Pharmigen (San Diego, CA), and Rac-1 polyclonal
antibody (SC217) was from Santa Cruz Biotechnology (Santa Cruz,
CA). Cycloheximide and actinomycin D were from Sigma (St. Louis,
MO), and platelet-derived growth factor (PDGF) was from Upstate
Biotechnology (Lake Placid, NY). Soluble human recombinant Fas
ligand and Annexin V-FITC apoptosis detection kit were from
Alexis (San Diego, CA). Recombinant mouse Fas/Fc chimera was
from R&D Systems (Minneapolis, MN), and FasL antibody was
from Santa Cruz Biotechnology. To generate mass culture constitu-
tively expressing the rac1 gene we used the expression plasmid
pLNCX-rac1. This plasmid contains the human rac1 gene carrying
an activating mutation (Leu 61) as a full-length cDNA under the
transcriptional control of the cytomegalovirus promoter. Also the
neomycin resistance gene was incorporated into the plasmid. pZ-
IPneo plasmid and derived expression vector for constitutively
active Rac1 (QL) subcloned into the BamHI site were used for
transient expression assays. Fas ligand luciferase reporter constructs
encoding for a 0.9-kb fragment of the FasL promoter as well as two
mutated forms in the 21008-kb site and 21048 AP-1 site, respec-
tively, were kindly provided by Dr. Douglas Green (La Jolla Insti-
tute for Allergy and Immunology, San Diego, CA).
Cell Transfections
NIH 3T3 cells were maintained in DMEM (Life Technologies, Gaith-
ersburg, MD) supplemented with 10% newborn calf serum (NCS)
under standard conditions of temperature (37°C), humidity (95°C),
and carbon dioxide (5%). Generation of cell lines overexpressing the
indicated genes was carried out by transfection of NIH 3T3 cells
with the pLNCX-rac1 vector by the calcium phosphate method.
Control cells were transfected with the empty pLNCX vector and
selected as the rac1-transfected cells. The day before, cells were
seeded at a density of 1 3 105 cells/100-mm dishes. Transfection
was carried out by using 1 mg of the indicated DNA and 20 mg of
DNA carrier. After 16 h of incubation, cells were washed with saline
phosphate buffer and fed with DMEM supplemented with 10%
NCS. One day later, geneticin (G418, Life Technologies) was added
to the medium and resistant colonies were pooled 2 wk later.
Analysis of DNA Fragmentation by Ethidium
Bromide Staining
Equivalent numbers of cells (3 3 105) of each cell line were seeded
into 10-cm dishes and grown in DMEM supplemented with 10%
NCS 72 h before treatments. After the indicated incubation periods,
the total cell population (adherent and detached cells) was collected
and lysed in 400 ml of 100 mM NaCl, 10 mM Tris-HCl, pH 8.0, 25
mM EDTA, 0.5% SDS. Lysates were incubated 5 h at 55°C with 0.2
mg ml21 proteinase K, and after that the genomic DNA was pre-
cipitated at 4°C overnight with 5 M NaCl to a final concentration of
1 M. Lysates were centrifuged at 13,000 rpm during at least 6 h, and
the pellet was eliminated. After extraction with an equal volume of
phenol:chloroform:isoamyl alcohol (25:24:1, vol/vol/vol) followed
by re-extraction with chloroform:isoamyl alcohol (24:1, vol/vol),
DNA was precipitated at 220°C overnight by addition of 0.1 vol-
ume of 3 M sodium acetate, pH 5.3, and 1 volume of isopropanol.
Precipitated DNA was collected by centrifugation at 13,000 rpm for
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2 h at 4°C, washed with ice-cold 70% ethanol, and air-dried. DNA
was then resuspended in 10 mM Tris-HCl, pH 7.5, 1 mM EDTA (TE
buffer) and treated with 0.5 mg ml21 RNAse at 37°C. DNA samples
were fractionated by electrophoresis in a 1.8% TBE-agarose gel at 60
V and visualized by ethidium bromide staining.
Western Blot Analysis of Protein Expression
Cells were grown under standard conditions until reaching 75%
confluence, or serum-starved until needed in the experiment. Cells
were washed twice with TD buffer (137 mM NaCl, 5 mM KCl, 1 mM
Na2HPO4, 20 mM Tris, pH 7.4), and lysed in 300 ml of ice-cold lysis
buffer (50 mM Tris, pH 7.4, 0.25% NP-40, 0.25% SDS, 150 mM NaCl,
15 mM b-glycerophosphate, 10 mM NaPPi, 50 mM NaF, 10 mg/ml
aprotinin, 1 mM phenylmethylsulfonyl fluoride). Nuclei and deter-
gent-insoluble material were removed by centrifugation at 13,000
rpm for 15 min. The resulting supernatants were analyzed for
estimation of total cell protein (Bio-Rad, Las Rosas, Spain), and
equal amounts of cell lysates (30 mg) were boiled at 95°C for 3 min
in SDS-polyacrylamide gel electrophoresis sample buffer. For West-
ern blot analysis, proteins were electrophoresed onto 15% (cyto-
chrome c), 12% (Rac1), or 10% (Fas Ligand) gels. Resolved proteins
were transferred to nitrocellulose and blots were blocked in 5%
nonfat dried milk in TTBS (0.05% Tween 20) and were incubated
with the appropriate antibodies at 1/1000 dilutions and developed
by enhanced chemiluminescence (Amersham, London, United
Kingdom).
Reverse Transcription-Polymerase Chain Reaction
(RT-PCR) for FasL Expression
The expression of FasL was determined by RT of total RNA fol-
lowed by PCR. Cells were grown under 75% confluence, and where
indicated, serum was removed for 24 h. Then the cells were washed
twice with TD, and total RNA was isolated with an Ultraespec-
IIRNA isolation kit (Biotecx, Las Rosas, Spain) according to the
manufacturer’s protocol. cDNA was synthesized by extension of
primers with avian myeloblastosis reverse transcriptase (Promega,
Madison, WI) in a mixture containing 1 mg of total RNA during 1 h
at 37°C. PCR of the cDNA was performed in a final volume of 20 ml
containing all four dNTPs, 1.5 mM MgCl2, 2.5 units of AmpliTaq
(Perkin Elmer-Cetus, Norwalk, CT), and each primer at 0.2 mM by
using the geneAmp 2400 PCR system (Perkin Elmer-Cetus). The
amplification cycles were 92°C for 20 s, 55°C for 30 s, and 72°C for
1 min. The PCR products were resolved by electrophoresis on a
1.6% agarose gel after 40 cycles (471-bp human FasL fragment) or
after 20 cycles (400-bp human b-actin) and visualized by ethidium
bromide staining. Amplification of b-actin served as control for
sample loading and integrity. The following primers were designed
to discriminate between the amplification of cDNA and contami-
nating genomic DNA: hFasL-forward: 59-TAAAACCGTTTGCT-
GGGGC-39, hFasL-reverse: 59-CTCAGCTCCTTTTTTCAGGGG-39,
b-actin-forward: 59-AATCTGGCACCACACCTTCTACA-39, and
b-actin-reverse: 59-CGACGTAGCACAGCTTCTCCTTA-39.
Measurement of Protease Activity
Cells with or without serum treatment were lysed with 300 ml of
0.5% NP-40, 0.5 mM EDTA, 150 mM NaCl, and 50 M Tris, pH 7.5.
Aliquots (50 ml) of the extracts were incubated with 40 mM tetrapep-
tide substrate, 10 mM HEPES, pH 7.5, 0.05 M NaCl, and 2.5 mM
DTT in 200 ml of reaction mixture for 2 h at 37°C. The fluorescence
of released 7-amino-4-methyl-coumarin (AMC) was measured by
using an excitation wavelength of 365 nm and an emission wave-
length of 450 nm.
Isolation of Mitochondria and Preparation of
Mitochondrial Extracts
The cells were submitted to the indicated treatments, washed twice
with TD, and tripsinized by using isolation medium (0.32 M su-
crose, 1 mM EDTA, 10 mM Tris-HCl [pH 7.4]), and 0.1% bovine
serum albumin (fatty acid free). Then, cells were homogenized
manually with a Potter-Ewelgein and samples centrifuged at 2000 3
g for 3 min. The precipitate was discarded, and the supernatant was
centrifuged again at 12,500 3 g for another 10 min to yield the crude
mitochondrial pellet. To the supernatant (the cytosolic fraction)
protein inhibitors 1 mM phenylmethylsulfonyl fluoride, and 10
mg/ml aprotinin (Sigma) were added, and samples stored at 270°C
until further analysis by Western blot. The mitochondrial pellet was
resuspended in lysis buffer (20 mM Tris-HCl, pH 8.0, 0.2 mM EDTA,
10% glycerol, 0.35 M NaCl, 1% Triton X-100, and 1 mM DTT). The
mitochondrial suspension was vigorously vortexed and allowed to
stand on ice for 15 min. The mitochondrial lysate was then centrifu-
gated at 45,000 rpm for 1 h. Protein was determined in the super-
natant and fractions were frozen and stored at 270°C until further
analysis for cytochrome c content by Western blot analysis with a
specific antibody as described above.
Transient Transfections
Murine NIH 3T3 fibroblasts were grown in DMEM with 10% new-
born calf serum, 1 mM glutamine (Life Technologies) and 25,000
units of penicillin and 25,000 mg/ml streptomycin (Life Technolo-
gies). For transient expression assays, cells were transfected in
60-mm dishes by the calcium phosphate method as described in
Montaner et al. (1999). The amount of plasmidic DNA was kept
constant at 10–12 mg/plate with the corresponding empty vector,
and the total amount of DNA was kept at 25 mg/60-mm dish with
calf thymus DNA (Boehringer Mannheim, Basel, Switzerland). After
the precipitate was removed, cells were incubated in DMEM, 0.5%
fetal bovine serum for 24 h and harvested for luciferase assay as
described in Montaner et al. (1999).
Gene Expression Analysis
Analysis of the FasL promoter activity was performed by cotrans-
fection of the expression vector for Rac1-QL with the hFasL-Luc
reporter or its mutated forms in the kB site or AP-1 site separately.
Cells were harvested 24 h after transfection and the protein extracts
were prepared by lysis with 150 ml/60-mm dish of 13 cell culture
lysis reagent (Promega) containing 25 mM Tris-phosphate, pH 7.8, 2
mM DTT, 2 mM 1,2-diaminocyclohexane-N,N,N9,N9-tetraacetic
acid, 10% glycerol, and 1% Triton X-100. The total amount of protein
was determined with a commercial kit based on the Bradford
method (Bio-Rad). Protein (20 mg) was assayed for luciferase activ-
ity by using a commercial kit (Promega).
Analysis of Changes in Mitochondrial
Transmembrane Potential
To measure DCm, both NIH 3T3 and Rac-1-transfected cells grown
in the presence or absence of serum were incubated with 100 nM
JC-1 (Molecular Probes, Eugene, OR) added to the culture media for
15 min at 37°C. Cells were then washed in phosphate-buffered
saline and analyzed on a FACScan flow cytometer (Becton Dickin-
son, Mountain View, CA) by using both the green (FL-1) and red
(FL-3) channels. At least 10,000 events were collected per sample.
Measurement of Reactive Oxygen Species (ROS)
Production and Cell Viability in Relation with
Changes in DCm
Cells were incubated during 15 min at 37°C with the potential-
sensitive dye 3,39-dihexyloxacarbocyanine iodide, 40 nM (DioC6;
Molecular Probes) and the ROS-sensitive dye hydroethidine, 2 mM
(HE; Molecular Probes). After incubation, cultures were washed in
phosphate-buffered saline and analyzed on a FACScan flow cytom-
eter. To determine the relationship between viability and changes in
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DCm, DioC6-stained cells were incubated with propidium iodine
(PI) during 10 min as described in Lo´pez-Collazo et al. (1998).
RESULTS
Apoptosis Induced by Rac in NIH 3T3 Requires
Protein Synthesis
We have previously demonstrated that overexpression of
the rho gene from A. californica and the human rho A, rac-1,
and rho C genes in NIH 3T3 cells can induce apoptosis under
serum deprivation (Esteve et al., 1995, 1998; Jime´nez et al.,
1995). To better understand the mechanisms involved in this
process, we have focused on rac-1 gene. To that end, we first
established an NIH 3T3 fibroblast cell line that stably ex-
presses the oncogenic version of Rac-1 protein, which con-
tains a mutated leucine 61 (Rac1). After transfection with
calcium phosphate and selection for neomycin resistance,
cells were characterized by Western blot by using a Rac1-
specific antibody (Figure 1A). Apoptosis in the rac transfec-
tants was measured by DNA fragmentation after serum
deprivation. As shown in Figure 1B, a clear DNA degrada-
tion pattern, typical of cell death by apoptosis, was observed
in the selected cells overexpressing the Rac1 protein. By
contrast, the parental NIH 3T3 cells, transfected with the
empty plasmid and selected for neomycin resistance,
showed no significant internucleosomal DNA degradation
under similar conditions (Figure 1B).
We treated cells with actinomycin D or cycloheximide to
test whether protein synthesis was necessary to induce ap-
optosis or whether all the components necessary for apopto-
tic signal transduction were already present in cells (Figure
1B). Rac-induced apoptosis was inhibited in the presence of
both inhibitors, an indication that protein synthesis was
required. We tested whether growth factors such PDGF
were capable of suppressing apoptosis induced by serum
deprivation in the Rac1-expressing cells. As shown in Figure
2A, apoptosis induced by Rac1 under serum starvation was
completely inhibited by PDGF. The same effect was ob-
served when fibroblast growth factor (FGF) was used under
similar conditions (our unpublished results). Thus, specific
growth factors can provide survival signals that prevent
cells expressing Rac1 to undergo apoptosis after serum de-
privation.
Caspase-3 Mediates Rac1-induced Apoptosis
Apoptotic responses in most cells are known to involve the
activity of specific proteases called caspases. Caspases 8 and
9, known as initiator caspases, have been widely linked to
the central pathway of apoptosis induction, whereas
caspase-3 appears to be required for many of the character-
istic apoptotic nuclear changes and is therefore termed an
effector caspase (reviewed in Nun˜ez et al., 1998). Specific
competitive inhibitors and fluorescent substrates have been
designed for caspase-1 and -3 from knowledge of their se-
quence recognition specificity. Cell death can be blocked
upon treatment of cells with these specific inhibitors (Ni-
cholson et al., 1995).
To test whether Rac1 initiated an apoptotic signal medi-
ated by some caspases we evaluated the effect of caspase
inhibitors on the apoptotic responses induced by Rac1.
Caspase-3 recognizes Asp-Glu-Val-Asp (DEVD) and the al-
dehyde DEVD-CHO has been proved to be a specific inhib-
itor of this protease. Treatment of cells overexpressing
Rac1-QL with DEVD-CHO inhibited the cell death induced
by serum deprivation but had no effect in control cells
(Figure 2A). In contrast to DEVD-CHO, the YVAD-CHO
peptidem, which inhibits specifically caspase-1 and recog-
nizes the sequence Tyr-Val-Ala-Asp (YVAD), was not effec-
tive in blocking the apoptotic response at the same concen-
tration as that of DEVD-CHO. Furthermore, treatment of
cells with double the concentration of caspase-1 inhibitors
still had no effect in Rac-1-overexpressing cells or control
cells. Therefore, YVAD was a negative control, in agreement
with the fact that caspase-1 is implicated mostly in inflam-
matory processes but not in apoptosis in most of the cell
types investigated (Thornberry and Lazebnik, 1998). Viabil-
Figure 1. Induction of apoptosis by overexpression of the human
Rac protein needs mRNA and proteins synthesis. (A) NIH 3T3 cells
were transfected with the appropriate plasmids carrying the human
gene rac-1 activated by a Leu 61 mutation (QL mutant). Pools of
transfected cells were selected for geneticin resistance and equiva-
lent amounts of protein lysates were analyzed by Western blot for
the level of expression of the protein by using a specific antibody.
Control indicates extracts from cells transfected with the empty
vector, pLNCX. Rac1 indicates the constitutively active pLNCX-
Rac1 QL mutant. The arrow on the right indicates the position of
Rac1QL protein. (B) Analysis of apoptosis by the DNA fragmenta-
tion assay after serum deprivation. Cells were incubated for 24 h in
DMEM with or without serum and in presence of 50 mM cyclohex-
imide (CHX), actinomycin D (ACT. D). Gel shows the DNA ladder
after staining with ethidium bromide.
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ity and aspect of cells overexpressing the Rac1 protein in the
absence of serum and treated with protease inhibitors was
similar to control cells, and no signs of death were detected
by DNA analysis (Figure 2B).
The above-mentioned results suggested that Rac1-in-
duced apoptosis is mediated by caspase-3 but not by
caspase-1. To further confirm that caspase-3 activation was
involved in Rac1-induced apoptosis, cytosolic extracts from
serum-depleted cells overexpressing Rac1-QL were sub-
jected to protease activity assay by using tetrapeptide sub-
strates that incorporate a photometric cleaving group
(AMC). Enzymatic cleavage after DEVD treatment was de-
tected in Rac-1 overexpressing cells as early as 6 h after
serum deprivation and increased thereafter at 12 and 24 h
(Figure 3). However, no increase in caspase-1 protease ac-
tivity was detected under similar conditions (Figure 3), con-
sistent with the failure of the tetrapeptide YVAD-CHO to
prevent Rac-induced apoptosis (Figure 2). Cell lines express-
ing Rac1 and grown in the presence of serum showed only
a partial activity for caspase-3, equivalent to one-tenth of
that observed in the serum-deprived cells. Moreover, paren-
tal NIH 3T3 cells showed only a marginal increase of
caspase-3 activity under similar experimental conditions.
These results taken together confirm that programmed cell
death induced by serum deprivation in cells overexpressing
activated Rac1 involves caspase-3 but not caspase-1.
Rac1-induced Apoptosis Occurs in the Absence of
Cytochrome c Release to the Cytosol
Cytochrome c is a mitochondrial protein involved in the
respiratory chain. This molecule is encoded by a nuclear
gene and synthesized as a cytoplasmic precursor molecule,
apocytochrome c, which is translocated to mitochondrial
intramembranous space. Translocation of cytochrome c from
mitochondria to cytosol has been shown to be a crucial step
in activation of the programmed cell death in various death
models (Krippner et al., 1996; Liu et al., 1996; Kluck et al.,
1997; Yang et al., 1997). Once released, it interacts with other
cytoplasmic components to initiate the activation of the ex-
ecution caspases, which leads to the subsequent apoptosis.
Figure 2. Effect of caspase protease
inhibitors on Rac-induced apopto-
sis. Rac1 and control NIH 3T3 cells
were incubated in either DMEM
supplemented with 10% NCS (1) or
DMEM without serum (2). The
caspase-3 inhibitor acetyl-DEVD-
CHO (50 mM) (A) or the caspase-1
inhibitor acetyl-YVAD-CHO (100
mM) (B) was added and cells incu-
bated for an additional period of
24 h. After this period, cells were
analyzed for induction of apoptosis
by the DNA fragmentation analysis
as described in MATERIALS AND
METHODS. Where indicated, DMEM
supplemented with PDGF (100 nM)
was used. Control, NIH 3T3 cells;
Rac1, NIH 3T3 cells overexpressing
the mutated Rac1-QL protein.
Figure 3. Caspase-3 activation in apoptosis induced by Rac1. NIH
3T3 cells constitutively expressing the Rac1QL protein and cells trans-
fected with the empty plasmid (c) were cultivated for 24 h in DMEM
supplemented with 10% new born calf serum (1) or DMEM without
serum (2). The cells were collected at 0, 6, 12, and 24 h after treatment
and cytoplasmic extracts were tested for protease activity by using
specific substrates as indicated in MATERIALS AND METHODS.
Caspase-1 and caspase-3 enzyme activity is expressed as fold activa-
tion over basal levels. Data are representative of four experiments
performed in triplicates, with similar results. Bars represent SD.
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Liu et al. (1996) demonstrated that cytochrome c is required
for the activation of caspase-3. However, some apoptotic
pathways can act independently of cytochrome c release. To
test whether there was translocation of cytochrome c from
mitochondria to cytosol in our system, we treated the cells
with or without serum, isolated the mitochondria and cy-
tosol by differential centrifugation, and performed a West-
ern blot analysis by using a monoclonal antibody against
cytochrome c (Figure 4A). Cytosol from cells incubated in
the absence of serum, therefore, induced to apoptosis, did
not show any significant increase in the content of cyto-
chrome c protein at a time when apoptosis was detectable by
the appearance of the DNA ladder (Figure 4B). Furthermore,
in these serum-starved cells, cytochrome c was clearly de-
tectable in the mitochondria at similar levels to those of
control cells. Finally, the results observed in the Rac1-ex-
pressing cells were not distinguishable from those of the
parental cells in the presence or absence of serum depriva-
tion. The above-mentioned results indicate that the cytosolic
accumulation of cytochrome c is not an event involved in
triggering apoptosis in the Rac1-expressing cells.
Rac-1 Increases ROS Production and Elevates the
Membrane Potential of the Mitochondria
The lack of a clear role for cytochrome c led to the search of
other targets that could be involved in apoptosis induced by
Rac-1. In the following experiments we investigated the
early changes in DCm and production of ROS. Although
NIH 3T3 cells did not exhibit significant changes in DCm
after serum deprivation, determined by JC-1 staining, a clear
hyperpolarization was observed in the rac1-transformed
cells 4 h after serum starvation. The rise of JC-1 red fluores-
cence (FL-3) in this cell line indicates an increase of DCm
Figure 4. Rac1-induced apoptosis progress in the absence of cyto-
chrome c accumulation in the cytosol. (Left) NIH 3T3 cells (Control)
and Rac1-expressing cells (Rac1) were incubated in DMEM medium
with (1) or without (2) serum for 24 h. After that, cells extracts
were obtained and processed for cytochrome c analysis. Both cyto-
solic (Cytosol) and mitochondrial preparations (Mitochond.) were
tested for the presence of cytochrome c by Western blot analysis, by
using a monoclonal antibody against cytochrome c. Cyt. C indicates
purified cytochrome c. The arrow indicates the position of the
cytochrome c. (Right) Parallel cultures of NIH 3T3 cells (Control)
and Rac1-expressing cells (Rac1) were incubated in DMEM medium
with (1) or without (2) serum for 24 h cells and then analyzed for
induction of apoptosis by the DNA fragmentation analysis as de-
scribed in MATERIALS AND METHODS.
Figure 5. Rac1 induces mitochondrial hyperpolarization. Rac1-transformed cells and NIH 3T3 cells were cultured in the presence or absence
of serum during 4 h. Changes in DCm were measured by using JC-1 uptake by flow cytometry in both green (FL-1) and red (Fl-3) channels.
White peaks represent JC-1 uptake in the presence of serum (arrow), whereas colored peaks indicate JC-1 stained cells under serum
deprivation conditions. A representative result of three experiments is shown.
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(Figure 5). However, fluorescence in this channel was re-
duced after 24 h of serum deprivation in Rac-1-transformed
cells, probably due to the disruption of the mitochondrial
inner membrane and a concomitant loss of DCm at this time
(our unpublished results). These results were confirmed by
double staining with the dye DioC6 (sensitive to membrane
potential) and the vital dye PI, where we observed early
changes of DCm (FL-1), specifically in the rac1 cells after
serum withdrawal (Figure 6). As well, high changes were
observed at 16 h of serum starvation in the same cell line,
which were accompanied by an elevation in the PI fluores-
cence (FL-3). This suggests a relationship between mitochon-
drial membrane hyperpolarization and cell death in this
context (Figure 6). Furthermore, an increase in ROS levels in
rac1-transformed cells was observed at 16 h after serum
deprivation, determined by a significant elevation of red
fluorescence of HE-stained cells, suggesting a possible role
for these species in the cell death.
Fas Ligand Is Synthesized in Rac1-induced Apoptosis
and It Is Required for Induction of Apoptosis
The Fas/Fas ligand (FasL) pathway has been implicated as
an important cellular pathway mediating apoptosis in di-
verse cell types (reviewed in Ashkenazi and Dixit, 1999).
Other reports demonstrated that activation via the FasL
receptor stimulates the acid sphingomyelinase, leading to
synthesis of ceramide (Gulbins et al., 1996). We have re-
ported previously that in rho- and rac-transfectants the levels
of ceramides increase upon serum removal (Esteve et al.,
1995, 1998). In parallel, a reduction of the levels of sphingo-
myelin is observed, an indication that an endogenous sphin-
gomyelinase may be involved.
Next, we wanted to establish the possible correlation be-
tween induction of apoptosis by Rac and synthesis of FasL.
To examine this possibility we tested the expression of FasL
in Rac1-QL-overexpressing cells by using RT-PCR under
serum deprivation conditions. As shown in Figure 7A, FasL
mRNA expression was clearly observed in serum-starved
Rac1-QL-overexpressing cells but not in serum-depleted
control cells or in Rac1-QL cells grown with 10% NCS.
Amplification of b-actin was tested in all cell lines and
served as a control for sample loading and integrity. No
difference was observed in any of the samples tested. Similar
results were observed when the levels of FasL were tested
by Western blot analysis with a FasL antibody. As shown in
Figure 7B, the levels of FasL were strongly increased in
serum-starved cells. Finally, we examined whether induc-
tion of FasL was necessary for Rac-1-induced apoptosis. To
that end, cells were serum starved or kept in the presence of
serum and treated or not with FasFc, an antogonist of FasL
signaling (Fan et al., 1999). As shown in Figure 7C, FasFc
treatment induced a 50% reduction in the apoptotic re-
sponse. Thus, these results indicate that expression of Rac1
activates FasL synthesis, and that production of FasL is
necessary for the apoptotic response.
Rac1 Activates Fas Ligand Synthesis by
Transcriptional Regulation of Its Promoter
The above-mentioned results demonstrate the induction of
FasL synthesis by Rac1 after serum deprivation. Previous
results have demonstrated that FasL is regulated at tran-
scriptional levels by regulation of its promoter (Green and
Reed, 1998). Thus, we next investigated whether Rac-1 was
able to transcriptionally activate the Fas ligand promoter.
NIH 3T3 cells were cotransfected transiently with a plasmid
containing the FasL promoter joined to the luciferase gene as
a reporter, along with an increasing dose of the expression
plasmid containing the rac-1 gene. The results shown in
Figure 8 indicate that expression of the rac-1 gene induces
the transcriptional activation of the FasL promoter up to
2.5-fold, an effect that was dose-dependent upon the amount
of rac1 DNA used in the transfection. Moreover, this induc-
tion did not occur when rac1 was cotransfected with a mu-
tated version of the FasL promoter with an inactive NF-kB
site or an inactive AP-1 site. These results suggest that these
two signaling cascades (JNK-dependent and NF-kB-depen-
Figure 6. Rac1 increases both Dc and ROS pro-
duction. (A) Analysis of Dc alterations by DioC6
(FL-1) and cellular death by PI (FL-3) at indicated
times. (B) Relationship between ROS production
and changes in Dc. ROS were detected by using
HE (FL-3). Two representative results of four
experiments are shown.
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dent) may be required for Rac1-mediated induction of the
Fas ligand promoter.
Ceramides and FasL Cooperate in Rac-mediated
Apoptosis
Because both ceramide levels and FasL levels appear to be
up-regulated in serum-starved Rac1-overexpressing cells,
we next wanted to assess the effects of these two signaling
components and their possible relationship during induc-
tion of cell death. To that end, we incubated cells in the
presence of FasL along with 10% serum (NCS). Different
concentrations were tested, and incubation proceeded up to
48 h. Treatment of the cells with FasL was not sufficient to
induce apoptosis under any condition tested (our unpub-
lished results). However, when this incubation was carried
out in the absence of serum, the Rac1-QL cells underwent
apoptosis much earlier with regard to the untreated cells in
an interval from 15 to 16 h upon treatment (Figure 9A), that
is, 5–6 h earlier that cells deprived of serum in the absence
of FasL. Incubation of the parental cells. NIH 3T3 cells, with
the permeable synthetic ceramide C2 in the presence of
serum during 48 h had no effect in the induction of apoptosis
Figure 7. FasL is generated in Rac1-expressing cells after serum
deprivation and it is necessary for apoptosis. (A) NIH 3T3 cells
stably expressing Ras-1QL protein (Rac1) or control NIH 3T3 cells
(Control) were incubated in DMEM with (1) or without (2) serum
for 24 h. Then, cells were processed for FasL expression determined
by RT-PCR as described in MATERIALS AND METHODS. FasL
expression in shown on the left (Fas Ligand), and as control, the
b-actin expression (b-Actin) was determined with the same samples
in parallel reactions. Negative control refers to an RT-PCR amplifi-
cation without primers. (B) Western blot analysis of FasL levels in
NIH 3T3 and Rac1 cells in the presence and absence of serum. (C)
Cells were incubated with FasFc (0.2 mg/ml) either in control me-
dium or without serum for 24 h. Cell death was estimated by flow
cytometry (Annexin V) and expressed as percentage of the value of
Rac1 without serum for each experiment (cell death range: 22–38%).
Data are the mean 6 SD from three independent experiments.
Figure 8. Rac1QL activates transcription of the hFasL promoter
through the kB and AP-1 sites. NIH 3T3 fibroblasts were cotrans-
fected with increasing amounts of Rac1QL together with 3 mg of the
luciferase reporter constructs containing a 0.9-kb fragment of the
human Fas L promoter (left), a mutated form deficient in NF-kB
binding (middle), and a mutated form deficient in AP-1 binding
(right). Luciferase activity was determined 24 h after transfection.
Results are expressed as luciferase activity per milligram of protein
extracts. Overexpression of Rac1QL in NIH 3T3 cells induces tran-
scriptional activation of the FasL promoter in a dose-dependent
manner (left). Transcriptional regulation of the hFasL promoter by
Rac1QL is dependent on functional kB (middle) and AP-1 (right)
sites. Data represent the mean of a single experiment performed in
triplicate 6 SD. Same results were observed in three independent
experiments.
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(Figure 9B). In contrast, when cells expressing the Rac1
protein were treated with the permeable synthetic ceramide
C2 under similar conditions, it was sufficient to induce mas-
sive DNA fragmentation (Figure 9B).
The above-mentioned results demonstrate that neither
FasL nor ceramides alone are sufficient to trigger apoptosis
in NIH 3T3 cells. Therefore, these cells do not have the
complete machinery for induction of apoptosis by either
ceramides or FasL. However, in cells overexpressing the
Rac1 protein, addition of either ceramides or FasL was suf-
ficient for a massive induction of apoptosis. Thus, the pres-
ence of these two signals seems to play an important role in
the induction of apoptosis in this cellular system. These
results suggest that at least two complementary signals are
required for the induction of apoptosis in NIH 3T3 cells.
Because Rac1 provides both the generation of ceramides and
the synthesis de novo of FasL, a possible explanation was
that the mechanism for induction of apoptosis by Rac1 in-
volved the simultaneous activation of these two signals.
To test this hypothesis, we incubated the parental NIH
3T3 cells with FasL and ceramides for 24 h in the presence of
serum. As shown in Figure 9C, apoptosis was triggered,
shown by the appearance of a DNA ladder similar to that of
the Rac1 cells after serum deprivation. Thus, the simulta-
neous addition of ceramides and FasL to the parental NIH
3T3 cells produced an equivalent effect to serum withdrawal
in the Rac1 cells, resulting in the induction of apoptosis.
DISCUSSION
The superfamily of small GTPases regulates signaling path-
ways that underlie a wealth of activities, including growth
and differentiation, in organisms ranging from yeast to hu-
mans. Although Rho proteins, a family of small GTPases,
were initially shown to have a role in cytoskeletal remodel-
ing, it is now known that these GTPases are involved in
several other cellular processes such as transcriptional acti-
vation, growth control, metastasis, development, and apo-
ptosis.
Our group provided the first evidence that Rho proteins
could be implicated in the regulation of apoptosis (Jime´nez
et al., 1995). Expression of the A. californica Rho protein
(which primary structure is 95% identical to the human
RhoA protein), into NIH 3T3 murine fibroblasts, induced
apoptosis after serum deprivation. Since this first report,
several groups have also reported both positive and nega-
tive involvement of Rho proteins in apoptotic program,
depending on the cell line investigated. Thus, human RhoA,
RhoC, Rac1, Rac2, and Cdc42 proteins have been involved in
the induction of apoptosis in diverse cellular systems, in-
cluding fibroblasts (Esteve et al., 1998), thymocytes (Lores et
al., 1997), neurons (Bazenet et al., 1998), and epithelial cells
(Fiorentini et al., 1998). However, the precise mechanism
involved was still not resolved. Here, we provide evidence
of some of the critical signaling pathways by which Rac1
may induce apoptosis.
The results presented in this study demonstrate that Rac1
can induce apoptosis by a mechanism that involves protein
and mRNA synthesis, activates caspase-3, but not caspase-1,
and may require the simultaneous production of ceramides
and the synthesis of FasL by a complex mechanism that
involves JNK- and NF-kB-dependent signals. However, no
significant release of cytochrome c from mitochondria was
observed before the onset of the apoptotic program, suggest-
ing a pathway independent of cytochrome c release. In
keeping with this, hyperpolarization of the mitochondria
and generation of ROS was observed.
The murine fibroblasts cell line NIH 3T3, is not sensitive to
ceramides or FasL alone, but it is sensitive to the combined
action of both signals. NIH 3T3 cells expressing the Rac1
protein constitutively activate JNK and NF-kB signaling
pathways, even in the presence of serum (Perona et al., 1997;
Figure 9. Induction of apoptosis
by exogenous addition of FasL
and/or synthetic ceramides. Anal-
ysis of DNA fragmentation was
performed essentially as described
in MATERIALS AND METHODS.
Control, NIH 3T3 cells, and NIH
3T3 overexpressing Rac1 were in-
cubated in DMEM supplemented
with 10% NCS until they reached
70% confluence. At this time, cells
were incubated in DMEM with (1)
or without (2) serum, and treated
as follows. (A) Cells were incu-
bated with Fas ligand (50 ng/ml) in
the absence or presence of serum
for 19 h. (B) Cells were incubated
with C2 ceramide (100 mM) in the
presence or absence of serum for
48 h. (C) Cells were incubated with
Fas ligand (50 ng/ml) plus cer-
amides C2 (100 mM) in the presence
or absence of 10% NCS for 24 h.
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Montaner et al., 1998, 1999). Upon serum removal, produc-
tion of ceramides and FasL is observed, and the cells un-
dergo apoptosis. Finally, specific growth factors such as
PDGF or FGF efficiently inhibit the apoptotic response. From
these findings, we propose that Rac1 provides simultaneous
and specific cooperative signals for apoptosis. Moreover,
cells expressing the Rac1 protein seem to be “initiated”
because they are sensitive to ceramides, whereas parental
cells are not. Therefore, we can postulate that both initiation
and progression signals are needed in this cellular system to
induce apoptosis. Both ceramides production and FasL syn-
thesis would participate in this process as complementary,
but not sufficient signals.
Ceramides act as second messengers and trigger apoptosis
in many cell types. In FasL-sensitive cells, ceramide gener-
ation after receptor activation has been placed downstream
of the death adaptor proteins (Chinnaiyan et al., 1996). In
stress response and ceramide signaling, apoptosis involves a
Ras/ceramide-activated protein kinase as well as the Ras,
Raf-1, and MAPK ERK kinase (MEK) pathway. Akt is then
inactivated, causing the phosphorylation of Bcl-XL/Bcl2-
associated death promoter (BAD), which executes its pro-
apoptotic function by binding its antiapoptotic partner Bcl-2.
This results in the release of cytochrome c from mitochon-
dria to the cytosol, triggering cell death. How cytochrome c
escapes from mitochondria during apoptosis remains con-
troversial and more than one mechanism may be possible,
depending on the particular stimulus and the type of cell
involved (Green and Reed, 1998). Our results demonstrate
that ceramides can trigger apoptosis in the Rac1-expressing
cells but not in their parental counterparts. Furthermore, this
process is independent of cytochrome c release from mito-
chondria. Preliminary results indicated that sphingomyelin
levels decreased in Rac-1 transfectant cells upon serum re-
moval (Esteve et al., 1998), suggesting the involvement of an
endogenous sphingomyelinase. However, attempts to iden-
tify the signaling mechanism responsible for ceramides pro-
duction in Rac-transfectants were unsuccessful because nei-
ther glutathione nor desipramine, previously reported
inhibitors of neutral and acidic sphingomyelinases in other
cell types, affected sphingomyelinase activity in NIH 3T3
cells (our unpublished results). Furthermore, no inhibitory
effect was observed when cells were treated with fumonisin
B1, an inhibitor of ceramides synthesis, ruling out the pos-
sibility that ceramides production in Rac-1 cells was a con-
sequence of ceramides synthesis. Thus, further research will
be required to identify the specific enzymatic machinery
involved and the participation of ceramides in this process.
The mechanism for Rac1-induced apoptosis is indepen-
dent of cytochrome c release. In fact, and consistent with this
observation, we provide evidence that an increase of DCm
constitutes an important event in Rac-1-induced apoptosis.
This was confirmed by staining with both DioC6 and JC-1.
Also, when we used the mitotracker CMXRos these cells
exhibited high levels of red fluorescence after serum deple-
tion (our unpublished results). A growing body of evidence
indicates that a loss of DCm is an early step in apoptosis
(Zamzami et al., 1995; Hortelano et al., 1997). However,
recent studies suggest that it may not be a universal path-
way and it depends on the cellular type (Bossy-Wetzel et al.,
1997; Kim et al., 1997; Li et al., 1999; Samali et al., 1999).
Furthermore, it is well known that ROS are implicated in the
induction of apoptosis in several cell types (Li et al., 1999).
Thus, our results indicate a lack of cytochrome c involve-
ment, and a potential role of ROS generation in Rac1-in-
duced apoptosis, in keeping with recent results published by
other authors with other systems. On this regard, apoptotic
pathways have been described that are independent of cy-
tochrome c release. For instance, some stress signals and
cytokines can initiate the apoptotic signal transduction path-
way via JNK (reviewed in Basu and Kolesnick, 1998). More-
over, FasL can activate both death receptors and trigger
caspase activation and subsequent proteolysis without any
detectable changes in cytochrome c cellular localization
(Chang et al., 1998), consistent with the involvement of a
FasL- or tumor necrosis factor-a-dependent mechanism in
Rac1-induced apoptosis.
Signaling by FasL seems to be important in Rac1-induced
apoptosis. Several cell types can be activated to undergo
apoptosis after the interaction of selected ligands with cell
surface receptors. Among the death receptors, Fas (also
called CD95) (Trauth et al., 1989; Yonehara et al., 1989) and
the tumor necrosis factor receptor 1 (Bazzoni and Beutler,
1996) are the most well studied. Both trigger apoptosis upon
binding to their ligands, which are structurally related mol-
ecules. Activation of Fas receptor can trigger apoptosis by
mechanisms that involve or not cytochrome c release (Boldin
et al., 1995; Chinnaiyan et al., 1995; Stanger et al., 1995; Muzio
et al. 1996; Salvesen and Dixit 1997; Susin et al., 1997; Li et al.,
1998). Our results indicate that Rac1-induced apoptosis is
consistent with a Fas-dependent mechanism. Expression of
FasL induced by Rac1 was found to be controlled by the
transcriptional activation of both JNK- and NF-kB-depen-
dent signals, in agreement with recent findings that FasL
promoter holds AP-1 and NF-kB sites (Kasibhatla et al.,
1998). Furthermore, inhibition of FasL by an antogonist,
FasFc, strongly inhibited the induction of apoptosis by Rac1.
Both JNK and NF-kB play a critical role in Rac1-induced
apoptosis as coordinated signals required for FasL promoter
regulation. However, FasL was not sufficient to turn on the
apoptotic program and required the collaboration of a sec-
ond signal, which we proposed is the generation of cer-
amides. Because none of these events (FasL or ceramides)
was sufficient to induce apoptosis in NIH 3T3 cells, we
postulate the need of initiation and progression signals for
apoptosis induced by Rac1. It is important to point out that
in the Rac1 transfectants, there is a constitutive induction of
JNK and NF-kB activity, which does not translate into an
increase in FasL synthesis. Thus, additional negative or in-
hibitory signals that impinge into FasL translational regula-
tion may be regulated by growth factors. In this sense, the
initiation signal for apoptosis may imply JNK and NF-kB,
but not FasL synthesis. Thus, specific growth factors (PDGF,
FGF) may interfer with FasL production under conditions of
JNK and NF-kB activation.
The results presented here represents an important
progress in our understanding on how Rho proteins partic-
ipate in the regulation of apoptosis. Further research should
clarify those aspects that remain to be fully elucidated.
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